How to buy Anteris Technologies shares

Anteris Technologies Ltd is a medical devices business based in Australia. Anteris Technologies shares (AVR) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Anteris Technologies has a trailing 12-month revenue of around $10.3 million.

How to buy shares in Anteris Technologies

1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
3. Search for Anteris Technologies. Find the share by name or ticker symbol: AVR. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Anteris Technologies reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At today's price of $N/A, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
6. Check in on your investment. Congratulations, you own a part of Anteris Technologies. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Anteris Technologies share price

Use our graph to track the performance of AVR stocks over time.

Anteris Technologies shares at a glance

• Key figures

Information last updated 2020-09-25.

52-week range	AUDA$3.03 - AUDA$7.5
50-day moving average	AUDA$3.9186
200-day moving average	AUDA$5.1554
Target price	N/A
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	AUDA$-0.9895

Share Trading Account Offer

IG Share Trading Offer

AUD 8

Standard brokerage - Australian shares

Share Trading Account Offer

Competitive broker fees on Australian and international shares

• Brokerage - AU shares: From AUD 5 or 0.05%
• Brokerage - US shares: USD 0
• Sign-up process: Instant
• Support - After hours: Yes

Go to site

More info

Important: Share trading carries risk of capital loss.

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Anteris Technologies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Anteris Technologies Ltd by TradingView

Anteris Technologies financials

Revenue TTM	$10.3 million
Gross profit TTM	$8 million
Return on assets TTM	-76.35%
Return on equity TTM	-2.44%
Profit margin	-2.28%
Book value	1.58
Market capitalisation	$24.1 million

TTM: trailing 12 months

Anteris Technologies share dividends

We're not expecting Anteris Technologies to pay a dividend over the next 12 months.

Anteris Technologies share price volatility

Over the last 12 months, Anteris Technologies's shares have ranged in value from as little as $3.03 up to $7.5. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Anteris Technologies's is 0.9. This would suggest that Anteris Technologies's shares are less volatile than average (for this exchange).

Anteris Technologies overview

Anteris Technologies Ltd, a structural heart company, researches, develops, commercializes, and distributes various medical technologies and devices. It manufactures, distributes, and sells proprietary ADAPT regenerative tissue products; and researches and develops regenerative medicine and immunotherapies. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd is based in Toowong, Australia.

Frequently asked questions

• What percentage of Anteris Technologies is owned by insiders or institutions?

  Currently 28.745% of Anteris Technologies shares are held by insiders and 22.183% by institutions.

• When does the fiscal year end for Anteris Technologies?

  Anteris Technologies's fiscal year ends in December.

• Where is Anteris Technologies based?

  Anteris Technologies's address is: Toowong Tower, Toowong, QLD, Australia, 4066